Ceribell, Inc. - CBLL
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 14, 2026 | SCHEDULE 13G/A | The Global Value Investment Portfolio Management Pte Ltd | 4.2% | 1,572,146 | View |
| May 14, 2026 | SCHEDULE 13G/A | u.life fund | 4.2% | 1,572,146 | View |
| May 14, 2026 | SCHEDULE 13G/A | GVIP Ventures SPC-SP3 | 0.0% | 0 | View |
| May 14, 2026 | SCHEDULE 13G/A | Caroline Kwong | 4.2% | 1,572,146 | View |
| May 12, 2026 | SCHEDULE 13G/A | Xingjuan Chao | 4.9% | 1,893,995 | View |
| May 06, 2026 | SCHEDULE 13G/A | FMR LLC | 12.9% | 4,850,431 | View |
| May 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 12.9% | 4,850,431 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 10.6% | 3,928,666 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 10.6% | 3,928,666 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | ABG WTT-Ceribell Limited | 4.6% | 1,691,267 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | ABG V-Ceribell Limited | 4.6% | 1,691,267 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | Ally Bridge Group Global Life Science Capital Partners V, L.P. | 4.6% | 1,691,267 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | ABG Global Life Science Capital Partners V GP, L.P. | 4.6% | 1,691,267 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | ABG Global Life Science Capital Partners V GP Limited | 4.6% | 1,691,267 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. | 4.6% | 1,691,267 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | ABG-WTT Global Life Science Capital Partners GP, L.P. | 4.6% | 1,691,267 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | ABG-WTT Global Life Science Capital Partners GP Limited | 4.6% | 1,691,267 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | ABG Management Ltd. | 4.6% | 1,691,267 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | Ally Bridge Group (PE) LLC | 4.6% | 1,691,267 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | Fan Yu | 4.6% | 1,691,267 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.